XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating activities    
Net loss $ (485,285) $ (6,199,990)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Amortization and depreciation 130,761 119,557
Stock-based compensation 589,394 665,496
Amortization of deferred offering costs 192,647
Non-cash lease expense 55,156 58,335
Fair value change in warrant liability (779,796)
Debt termination costs reclassed to financing activities 132,091
Change in assets and liabilities:    
Accounts receivable (142,144) (555,639)
Inventory 800,546 415,013
Prepaid expenses 8,394 (144,031)
Accounts payable 80,885 76,899
Accrued expenses, deferred revenue, operating leases and other liabilities (430,744) (420,194)
Net cash provided by (used in) operating activities 151,905 (5,984,554)
Investing activities    
Purchase of property and equipment (27,587) (68,491)
Net cash used in investing activities (27,587) (68,491)
Financing activities    
Proceeds from issuance of common stock attributed to equity financings 414,037 3,350,467
Issuance costs related equity financings (261,832) (160,406)
Financing costs in connection with debt facility (297,942)
Share repurchases for the payment of employee taxes (118,372) (24,854)
Net cash (used in) provided by financing activities (264,109) 3,165,207
Net decrease in cash and cash equivalents (139,791) (2,887,838)
Cash and cash equivalents at beginning of period 1,460,042 5,322,493
Cash and cash equivalents at end of period 1,320,251 2,434,655
Supplemental non-cash financing and investing transactions:    
Unpaid issuance costs in accounts payable and accrued expenses 72,377 25,674
Modification of right-of-use asset and associated lease liability 111,898
Purchased property and equipment in accounts payable $ 10,026 $ 14,800